| 摘要 |
The invention relates to a pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of at least one angiotensin II antagonist, characterized in that the active principle combination is released in the body in a controlled (modified) manner, and to methods for the production thereof, their use as medicaments, their use for the prophylaxis, secondary prophylaxis and/or treatment of diseases as well as to their use for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of diseases.
|
